(Q53100163)

11 May 2018

http://europepmc.org/abstract/MED/27183625

title

The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses. (English)

1 reference

11 May 2018

http://europepmc.org/abstract/MED/27183625

author

Frederik Steyn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Glen M. Boyle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Trent M. Woodruff

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jamileh A Nabizadeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Helga D Manthey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Weiyu Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Alexander Widiapradja

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Barbara E Rolfe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Fazrena N Md Akhir

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Stephen M Taylor

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

20 April 2016

1 reference

11 May 2018

http://europepmc.org/abstract/MED/27183625

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

4783-4792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

Complement: a key system for immune surveillance and homeostasis

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Expression of complement protein C5a in a murine mammary cancer model: tumor regression by interference with the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Modulation of the antitumor immune response by complement

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Opposing roles for complement component C5a in tumor progression and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Myeloid-derived cells are key targets of tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

The role of the anaphylatoxins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Complement component 5a (C5a)

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Neurologic complications in adult living donor liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Tumor-associated neutrophils: new targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

The role and regulation of human Th17 cells in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Primary antitumor immune response mediated by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

Evidence for a cross-talk between human neutrophils and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1600210

21 January 2018

Identifiers

DOI

10.4049/JIMMUNOL.1600210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27183625%20AND%20SRC:MED&resulttype=core&format=json

release_hs7es5hnarbilhw2kjhtkmcmwy

6 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hs7es5hnarbilhw2kjhtkmcmwy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference